What a medication depletion panel should do
A premade vitamin bundle may miss the test a medicine actually needs. Long-term metformin can make B12 testing useful. Some people who use a proton pump inhibitor for a long time may need B12 or magnesium checked, but low-risk users do not need blanket screening. Carbamazepine may need sodium, blood-count, liver, and bone checks. Antipsychotics and steroids may need glucose checks.
Nutrient
Could this medicine lower or block a nutrient?
Metformin and B12 are the clearest example. Other links need the exact drug, duration, symptoms, and risk factors.
Safety
Is the real test about organ or electrolyte safety?
Some medicines need sodium, potassium, kidney, liver, CBC, glucose, lipids, ECG, or medicine-level monitoring instead of vitamins.
Cause
Could the abnormal result have another source?
Diet, bleeding, gut disease, kidney or liver problems, illness, and the condition being treated can mimic medication depletion.
Decision
What would this result change?
Testing is useful when it can change food, replacement, monitoring, the medicine plan, or the search for another cause.
The label 'depletion' is too narrow for many drugs. A normal vitamin panel doesn't prove a medicine is harmless, and one low nutrient doesn't prove the medicine caused it. Start with a verified regimen and the current monitoring guidance for each drug.
Save this test
Save the medicine-to-test reasoning, not only the lab flags
Keep the medicine list, symptom timing, selected test results, and next decision together. Save the reason for each test and what changed.
My Fog records information you enter. It does not tell you to stop, taper, switch, or supplement around a prescription.
How age, sex, pregnancy, diet, illness, and the exact medicine change the testing plan
Age, sex, pregnancy, diet, bleeding, kidney and liver function, growth, bone health, and the number of medicines can change which test is useful. They do not create one male panel, female panel, or age-based supplement stack.
Children
Use pediatric prescribing guidance and age-appropriate laboratory intervals. The 2026 Tahir review found only five metformin studies in children and teenagers, with very different deficiency estimates between trial and observational data. Adult B12 schedules don't automatically apply to children.
Teenagers
Growth, food restriction, heavy periods, sports load, bone development, and the reason for the medicine can create separate nutrient risks. Antiseizure, antipsychotic, steroid, or metformin monitoring should follow the exact pediatric drug and condition, not a commercial adult panel.
Adult women and men
The medicine-specific principle is the same. Menstrual blood loss can make CBC, ferritin, and iron studies relevant for some women, but that is not proof that a medicine depleted iron. Unexplained iron deficiency in men or people without menstrual blood loss needs its cause checked. Supplements alone can hide that cause.
Pregnancy and breastfeeding
Medication safety, folate and iron needs, active B12 testing, nausea, diet, and the reason for treatment need direct obstetric and prescribing review. Do not stop metformin, an antiseizure medicine, a psychiatric medicine, or another prescription because of an online depletion list. NICE recommends active B12 as the initial B12 test during pregnancy when deficiency is suspected.
Older adults
Low food intake, low stomach acid, frailty, kidney changes, falls, several prescribers, and drug interactions may raise the need for testing. Bring the bottles or a checked medicine list instead of relying on memory.
What to do before a medication and blood-test review
Before the appointment, make one exact medicine list. Include prescription drugs, over-the-counter products, injections, inhalers, patches, creams, eye or ear drops, vitamins, minerals, herbal products, and medicines taken only as needed. Add the dose, timing, start date, recent changes, and why you take each one.
Write what changed and when. Record numbness, tingling, burning feet, weakness, cramps, a racing heart, severe tiredness, pale skin, or a sore mouth. Add falls, bone pain, fractures, vomiting, diarrhea, appetite changes, heavy bleeding, and changes after a drug started or increased.
Ask what the result would change. Long-term metformin may call for B12, while some PPI use may call for magnesium. Carbamazepine or a water pill may call for sodium. Other medicines may need kidney or glucose tests. Sometimes no new blood test is needed.
Bring the latest CBC, kidney, liver, glucose, lipid, B12, folate, ferritin, vitamin D, magnesium, sodium, and potassium results you already have. Repeating a recent result without a reason adds cost without improving the review.
Tell the clinician and laboratory about every vitamin and supplement. B12 replacement can raise a B12 result without proving the cause is fixed. Biotin can interfere with some laboratory methods. Iron, magnesium, calcium, and other supplements can also interact with medicines.
Keep taking medicines and prescribed supplements unless the prescriber gives a different plan. Sudden changes can be more dangerous than the possible deficiency.
Fasting is not a rule for a medication review. Follow the instructions for the selected tests. A fasting glucose or lipid order may need different preparation from B12, CBC, sodium, creatinine, or vitamin D. If the instructions were not followed, tell the laboratory before collection.
Start with the exact medicine
List the generic name, dose, schedule, start date, reason, recent changes, and every nonprescription product.
Name the possible problem
Separate a nutrient concern from a side effect, interaction, organ-safety test, medicine level, or the illness being treated.
Choose the test that fits
Use the drug label, current guideline, symptoms, age, diet, kidney or liver function, pregnancy context, and other medicines to narrow the order.
Read results as a set
Keep the value, units, laboratory interval, related tests, symptoms, supplements, and collection conditions together.
Agree on the next decision
Ask whether the result changes food, replacement, the medicine plan, repeat timing, or a different investigation.
How to understand a medication-related panel
Start with the exact medicine, its purpose, and the suspected problem. Add why each test was chosen, the value and lab range, symptoms, diet, bleeding, kidney or liver health, and other products. End with the decision the result changes.
No targeted panel yet
No medicine-specific reason for the proposed bundle
Do not order a broad panel only because a drug appears on an online depletion chart. Verify the medicine, duration, symptoms, risk factors, current label or guideline, recent results, and the decision each test could change. A pharmacist or prescriber review may be the better first step.
Selected tests are in range
The selected medicine-specific tests are within the correct laboratory intervals
This lowers concern for the measured problems under those collection conditions. It doesn't prove that the medicine causes no side effects, that every nutrient is adequate, or that the medicine is unrelated to brain fog. Return to timing, dose, interactions, sleep, the treated condition, and other causes.
One targeted result is abnormal
One targeted nutrient or safety result is abnormal
Confirm that the result fits the symptom, medicine, method, and related tests. Decide whether the cause is the medicine, diet, bleeding, malabsorption, kidney or liver disease, another illness, or more than one factor. Replacement and medicine review are separate decisions.
Several results or symptoms need direct review
Several results are abnormal, symptoms are strong, or the findings suggest toxicity or organ problems
This needs direct medical review. Get urgent help for severe confusion, fainting, a seizure, chest pain, an uneven heartbeat, or marked weakness. Black or bloody stool, severe vomiting or diarrhea, yellow skin, very little urine, or signs of overdose also need urgent care.
The medicine may need a safety test, not a vitamin panel
A vitamin bundle can miss low sodium from carbamazepine, glucose changes from an antipsychotic or steroid, and kidney changes from another medicine. A drug can also cause sleepiness while routine blood tests stay normal.
See research details
Monitoring numbers belong to a named medicine, risk group, and source. They don't replace the current label or the prescriber's plan.
Keep the exact product, duration, symptoms, diet, gastrointestinal history, PPI or colchicine use, CBC, B12 method, and any replacement beside the result. Do not stop metformin solely because B12 is low.
Use B12 testing according to the medicine, symptoms, risk factors, and local guidance. Order folate, vitamin D, iron, magnesium, or another test only when a separate clinical reason exists.
Do not turn ordinary long-term PPI use into an automatic nutrient panel. Ask about duration, dose, indication, diarrhea, kidney disease, diet, other B12 risks, diuretics, digoxin, cramps, weakness, palpitations, seizures, and existing results.
Keep the disagreement visible. PPI exposure is a B12 risk factor in NICE guidance, but a low-risk user does not automatically need repeat B12 panels. Symptoms and added risk factors make the question stronger.
Do not apply one anticonvulsant panel to every medicine or use a nutrient result to change seizure treatment. Save the exact drug, seizure control, pregnancy plans when relevant, falls or fractures, diet, sun exposure, mobility, and current monitoring schedule.
A medication review should include the tests required for safety and effectiveness even when no vitamin or mineral test is needed.
Do not add a supplement stack to an antidepressant, antipsychotic, mood stabilizer, or sleep medicine from a generic chart. Review symptoms, diet, interactions, metabolic monitoring, and the exact evidence for that drug.
Save supplement use, kidney function, symptoms, and the laboratory method. A normal CBC or serum magnesium value cannot answer every tissue or clinical question by itself.
Use the medicine label and monitoring pathway where care is received. A private vitamin and mineral bundle can't replace a medicine review.
What you can do while the medication question is being checked
You can improve the quality of the review and support food intake without trying to treat every possible deficiency at once. When tests find a true deficiency, food and replacement have different jobs, especially if the medicine changes absorption.
Build one accurate medicine list
Photograph labels or bring the containers. Include dose, time, reason, prescriber, start date, missed doses, recent changes, over-the-counter drugs, supplements, inhalers, creams, drops, patches, injections, and as-needed products.
Use food to support the confirmed direction
B12 foods include fish, meat, poultry, eggs, dairy, and fortified cereals or nutritional yeast. Magnesium foods include beans, leafy greens, nuts, seeds, and whole grains. Vitamin D food sources include fatty fish and fortified foods. Iron can come from meat and seafood or from beans, vegetables, nuts, and fortified grains, with vitamin C helping nonheme iron absorption.
Know when food may not be enough
These can call for a replacement plan led by a clinician: a medicine-related absorption problem, marked deficiency, neurological symptoms, anemia, malabsorption, major gastrointestinal surgery, pregnancy, or kidney disease. Do not use a week of food changes as a safety test.
Record timing instead of guessing
For 1-2 weeks, record medicine times, meals, sleep, bowel symptoms, hydration, and when thinking problems, tingling, cramps, dizziness, weakness, or palpitations appear. Symptoms at predictable times can reveal a direct side effect or interaction even when nutrient tests are normal.
Ask a pharmacist to check the full regimen
A pharmacist can check duplicate products, interactions, doses, timing, monitoring requirements, and whether the medicine is still serving its purpose. In Australia, eligible people may have a GP-referred Home Medicines Review. US and UK readers can ask their pharmacy or primary-care team what medicine-review service is available.
Check the result, cause, kidney function, and drug interactions before starting high-dose vitamins, minerals, or injections. Do not stop the medicine on your own. Seek urgent help for a seizure, fainting, chest pain, severe confusion, one-sided weakness, bleeding, a severe allergy, overdose, or thoughts of self-harm.
What to save from a medication depletion review
Keep these together
- Every medicine and supplement, dose, timing, reason, prescriber, start date, recent change, missed doses, and as-needed use
- Symptoms, start date, daily timing, food and bowel context, bleeding, illness, falls, fractures, and what changed after each medicine change
- Each selected test, why it was chosen, value, units, laboratory interval, collection conditions, and related results
- Clinician or pharmacist interpretation, established cause, food or replacement plan, medicine decision, and safety warnings
- Repeat date and conditions, what improvement or harm to watch for, and the next decision
Question for the visit
“Which part of my medicine list creates a real nutrient or safety-monitoring question, which test would change care, and which broad tests can we avoid because they do not fit my medicines or symptoms?”
Sources for Medication Depletion Panel
Current metformin-containing product label, annual hematologic monitoring, B12 every 2 to 3 years, and risk context.
Periodic B12 assessment with long-term metformin, especially with anemia, neuropathy, or added risk.
Up to 1 in 10 product-information frequency, symptoms, risk factors, monitoring, correction, and do-not-stop advice.
Adult observational metformin comparison, selective B12 reduction, other measured vitamins, and study limit.
Long-term PPI safety evidence, low-risk routine monitoring limits, and magnesium disagreement.
PPI hypomagnesemia timing, serious symptoms, prolonged-treatment and co-medication monitoring context.
Six-study PPI and B12 meta-analysis, sample sizes, null pooled result, and low-risk monitoring limit.
Medicine risk factors, testing before replacement, pregnancy testing, indeterminate results, medicine-induced deficiency, and supplement limits.
Drug-specific CBC, liver, sodium, vitamin D, bone, symptom, and medicine-level monitoring.
Current antiseizure medicine and bone review, higher-risk and more favorable drug profiles, and fracture-risk context.
Antipsychotic baseline, 12-to-16-week and annual screening, glucocorticoid glucose monitoring, and other medicine-related glycemic risk.
Psychiatric medicine and nutrient-interaction review and limit on widespread supplementation.
Five-study pediatric metformin and B12 review, pooled estimates, heterogeneity, and evidence gap.
Food sources, medicine interactions, absorption, age and pregnancy context, and deficiency limits.
Food sources, serum-test limits, medicine-related risk, kidney context, and toxicity.
Food sources, medicine interactions, status, and supplement safety.
Food sources, sex and pregnancy needs, PPI evidence, absorption, and supplement risks.
Medicine and supplement disclosure, fasting variability, preparation honesty, and do-not-stop boundary.
Complete prescription, OTC, occasional, nonoral, and supplement list for medication reconciliation.
Australian pharmacist review, medicine gathering, GP report, follow-up, and management plan.
See each claim's sources
limitation
Medication-related laboratory monitoring is drug-specific and may involve nutrients, electrolytes, blood counts, kidney or liver function, glucose, lipids, or no new test rather than one universal depletion bundle.procedure
Current US labeling and ADA guidance support B12 monitoring during long-term metformin use, with closer attention when anemia, neuropathy, long duration, high dose, or other B12 risk factors are present.interpretation
A 2025 adult observational study found lower B12 with metformin but no difference in the other measured vitamins, supporting a targeted rather than blanket vitamin question.limitation
Current gastroenterology guidance does not support routine B12, bone-density, or kidney monitoring solely because a low-risk person takes a PPI, while FDA labeling supports selected magnesium monitoring during prolonged use or with added risk.research
A 2025 six-study meta-analysis found no long-term PPI association with total B12 or homocysteine and could not support routine B12 monitoring in low-risk users.procedure
Antiseizure medicine monitoring depends on the specific drug, with selected medicines raising sodium, CBC, liver, vitamin D, bone, or fracture-risk questions rather than one class-wide nutrient panel.procedure
ADA 2026 recommends diabetes screening at baseline, 12 to 16 weeks after starting a second-generation antipsychotic, and annually thereafter, and calls for glucose monitoring with recurrent or long-term glucocorticoid use.limitation
A 2026 review of psychiatric medicine and nutrient interactions does not recommend widespread supplementation and supports evaluation of people with a plausible individual risk.limitation
Serum magnesium is commonly used but reflects less than 1 percent of total body magnesium and does not fully measure body stores.limitation
PPI use for up to 10 years has not been associated with iron depletion or anemia in people with normal starting iron stores, although iron absorption and response to replacement can be reduced when iron deficiency exists.procedure
Lab preparation should follow the selected order, include disclosure of medicines and supplements, and should not involve stopping medicines without instructions.context
A 2026 pediatric metformin review found only five studies and widely differing deficiency estimates, so adult monitoring assumptions should not be copied to children without pediatric guidance.